1.Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214000, Jiangsu, China
2.Department of Radiology, the Second Affiliated Hospital, Medical College of Shantou University, Shantou 515000, Guangdong, China
3.Department of Basic Medicine, Xiamen Medical College, Xiamen 361000, Fujian, China
4.Department of Radiology, the Second Affiliated Hospital of Xiamen Medical College, Xiamen 361000, Fujian, China
* gyan@stu.edu.cn
纸质出版:2022-10
Scan QR Code
Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis[J]. 解放军医学杂志(英文版), 2022,9(5):618-627.
Nie YJ, Wu SH, Xuan YH, Yan G. Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis. Mil Med Res. 2022;9(1):21.
Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis[J]. 解放军医学杂志(英文版), 2022,9(5):618-627. DOI: 10.1186/s40779-022-00382-3.
Nie YJ, Wu SH, Xuan YH, Yan G. Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis. Mil Med Res. 2022;9(1):21. DOI: 10.1186/s40779-022-00382-3.
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic interstitial lung disease with no established treatment and is characterized by progressive scarring of the lung tissue and an irreversible decline in lung function. Chronic inflammation has been demonstrated to be the pathological basis of fibrosis. Emerging studies have revealed that most interleukin-17 (IL-17) isoforms are essential for the mediation of acute and chronic inflammation
via
innate and adaptive immunity. Overexpression or aberrant expression of IL-17 cytokines contributes to various pathological outcomes
including the initiation and exacerbation of IPF. Here
we aim to provide an overview of IL-17 family members in the pathogenesis of IPF.
Barratt SL , Creamer A , Hayton C , Chaudhuri N . Idiopathic pulmonary fibrosis (IPF): an overview . J Clin Med . 2018 ; 7 ( 8 ): 201 .
Martinez FJ , Collard HR , Pardo A , Raghu G , Richeldi L , Selman M , et al . Idiopathic pulmonary fibrosis . Nat Rev Dis Primers . 2017 ; 3 : 17074 .
Chanda D , Otoupalova E , Smith SR , Volckaert T , De Langhe SP , Thannickal VJ . Developmental pathways in the pathogenesis of lung fibrosis . Mol Aspects Med . 2019 ; 65 : 56 - 69 .
Lee JM , Yoshida M , Kim MS , Lee JH , Baek AR , Jang AS , et al . Involvement of alveolar epithelial cell necroptosis in idiopathic pulmonary fibrosis pathogenesis . Am J Respir Cell Mol Biol . 2018 ; 59 ( 2 ): 215 - 24 .
Song X , Qian Y . IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases . Cell Signal . 2013 ; 25 ( 12 ): 2335 - 47 .
Ito Y , Correll K , Zemans RL , Leslie CC , Murphy RC , Mason RJ . Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-alpha/EGFR signaling . Am J Physiol Lung Cell Mol Physiol . 2015 ; 308 ( 11 ): L1178 - 88 .
Aulakh GK . Neutrophils in the lung: “the first responders.” Cell Tissue Res . 2018 ; 371 ( 3 ): 577 - 88 .
Pelaia G , Gallelli L , D’agostino B , Vatrella A , Cuda G , Fratto D , et al . Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts . J Cell Physiol . 2007 ; 210 ( 2 ): 489 - 97 .
Cook SA , Schafer S . Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation . Annu Rev Med . 2020 ; 71 : 263 - 76 .
Montero P , Milara J , Roger I , Cortijo J . Role of JAK/STAT in interstitial lung diseases; molecular and cellular mechanisms . Int J Mol Sci . 2021 ; 22 ( 12 ): 6211 .
Prele CM , Yao E , O’donoghue RJ , Mutsaers SE , Knight DA . STAT3: a central mediator of pulmonary fibrosis? Proc Am Thorac Soc . 2012 ; 9 ( 3 ): 177 - 82 .
Jaffar J , Mcmillan L , Wilson N , Panousis C , Hardy C , Cho HJ , et al . Coagulation Factor-XII induces interleukin-6 by primary lung fibroblasts: a role in idiopathic pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol . 2021 ; 322 ( 2 ): L258 - 72 .
Celada LJ , Kropski JA , Herazo-Maya JD , Luo W , Creecy A , Abad AT , et al . PD-1 up-regulation on CD4 + T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production . Sci Transl Med . 2018 ; 10 ( 460 ): eaar8356 .
Yamaguchi S , Nambu A , Numata T , Yoshizaki T , Narushima S , Shimura E , et al . The roles of IL-17C in T cell-dependent and -independent inflammatory diseases . Sci Rep . 2018 ; 8 ( 1 ): 15750 .
Starnes T , Broxmeyer HE , Robertson MJ , Hromas R . Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis . J Immunol . 2002 ; 169 ( 2 ): 642 - 6 .
Yao Z , Painter SL , Fanslow WC , Ulrich D , Macduff BM , Spriggs MK , et al . Human IL-17: a novel cytokine derived from T cells . J Immunol . 1995 ; 155 ( 12 ): 5483 - 6 .
Fossiez F , Djossou O , Chomarat P , Flores-Romo L , Ait-Yahia S , Maat C , et al . T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines . J Exp Med . 1996 ; 183 ( 6 ): 2593 - 603 .
Korn T , Bettelli E , Oukka M , Kuchroo VK . IL-17 and Th17 Cells . Annu Rev Immunol . 2009 ; 27 : 485 - 517 .
Ding Y , Ao J , Ai C , Chen X . Molecular and functional identification of three interleukin-17A/F (IL-17A/F) homologues in large yellow croaker (Larimichthys crocea) . Dev Comp Immunol . 2016 ; 55 : 221 - 32 .
Kolls JK , Linden A . Interleukin-17 family members and inflammation . Immunity . 2004 ; 21 ( 4 ): 467 - 76 .
Yao Z , Fanslow WC , Seldin MF , Rousseau AM , Painter SL , Comeau MR , et al . Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor . Immunity . 1995 ; 3 ( 6 ): 811 - 21 .
Gaffen SL . Structure and signalling in the IL-17 receptor family . Nat Rev Immunol . 2009 ; 9 ( 8 ): 556 - 67 .
Mcgeachy MJ , Cua DJ , Gaffen SL . The IL-17 family of cytokines in health and disease . Immunity . 2019 ; 50 ( 4 ): 892 - 906 .
Ramirez-Carrozzi V , Sambandam A , Luis E , Lin Z , Jeet S , Lesch J , et al . IL-17C regulates the innate immune function of epithelial cells in an autocrine manner . Nat Immunol . 2011 ; 12 ( 12 ): 1159 - 66 .
Rickel EA , Siegel LA , Yoon BR , Rottman JB , Kugler DG , Swart DA , et al . Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities . J Immunol . 2008 ; 181 ( 6 ): 4299 - 310 .
Toy D , Kugler D , Wolfson M , Vanden Bos T , Gurgel J , Derry J , et al . Cutting edge: interleukin 17 signals through a heteromeric receptor complex . J Immunol . 2006 ; 177 ( 1 ): 36 - 9 .
Yang H , Zhu Y , Chen X , Li X , Ye S , Zhang R . Structure of a prokaryotic SEFIR domain reveals two novel SEFIR-SEFIR interaction modes . J Struct Biol . 2018 ; 203 ( 2 ): 81 - 9 .
Ely LK , Fischer S , Garcia KC . Structural basis of receptor sharing by interleukin 17 cytokines . Nat Immunol . 2009 ; 10 ( 12 ): 1245 - 51 .
Hadian Y , Bagood MD , Dahle SE , Sood A , Isseroff RR . Interleukin-17: potential target for chronic wounds . Mediators Inflamm . 2019 ; 2019 : 1297675 .
Qian Y , Liu C , Hartupee J , Altuntas CZ , Gulen MF , Jane-Wit D , et al . The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease . Nat Immunol . 2007 ; 8 ( 3 ): 247 - 56 .
Schwandner R , Yamaguchi K , Cao Z . Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction . J Exp Med . 2000 ; 191 ( 7 ): 1233 - 40 .
Rouvier E , Luciani MF , Mattei MG , Denizot F , Golstein P . CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene . J Immunol . 1993 ; 150 ( 12 ): 5445 - 56 .
Tiringer K , Treis A , Fucik P , Gona M , Gruber S , Renner S , et al . A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection . Am J Respir Crit Care Med . 2013 ; 187 ( 6 ): 621 - 9 .
Brodlie M , Corris PA , Lordan J , Ward C . Interleukin-17 and cystic fibrosis lung disease . Am J Respir Crit Care Med . 2012 ; 185 ( 1 ): 108 - 9 .
Zhang J , Wang D , Wang L , Wang S , Roden AC , Zhao H , et al . Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease . Am J Physiol Lung Cell Mol Physiol . 2019 ; 316 ( 3 ): L487 - 97 .
Li D , Guabiraba R , Besnard AG , Komai-Koma M , Jabir MS , Zhang L , et al . IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice . J Allergy Clin Immunol . 2014 ; 134 ( 6 ): 1422-32.e11 .
Kono M , Miyashita K , Hirama R , Oshima Y , Takeda K , Mochizuka Y , et al . Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease . Respir Med . 2021 ; 186 : 106534 .
Chambers RC , Mercer PF . Mechanisms of alveolar epithelial injury, repair, and fibrosis . Ann Am Thorac Soc . 2015 ; 12 ( Suppl 1 ): S16 - 20 .
Shaikh SB , Prabhu A , Bhandary YP . Interleukin-17A: a potential therapeutic target in chronic lung diseases . Endocr Metab Immune Disord Drug Targets . 2019 ; 19 ( 7 ): 921 - 8 .
Albanesi C , Cavani A , Girolomoni G . IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFNgamma and TNF-alpha . J Immunol . 1999 ; 162 ( 1 ): 494 - 502 .
Iwakura Y , Ishigame H , Saijo S , Nakae S . Functional specialization of interleukin-17 family members . Immunity . 2011 ; 34 ( 2 ): 149 - 62 .
Jovanovic DV , Di Battista JA , Martel-Pelletier J , Jolicoeur FC , He Y , Zhang M , et al . IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages . J Immunol . 1998 ; 160 ( 7 ): 3513 - 21 .
Gouda MM , Bhandary YP . Acute lung injury: IL-17A-mediated inflammatory pathway and its regulation by curcumin . Inflammation . 2019 ; 42 ( 4 ): 1160 - 9 .
Wilson MS , Madala SK , Ramalingam TR , Gochuico BR , Rosas IO , Cheever AW , et al . Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent . J Exp Med . 2010 ; 207 ( 3 ): 535 - 52 .
Golebski K , Ros XR , Nagasawa M , Van Tol S , Heesters BA , Aglmous H , et al . IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation . Nat Commun . 2019 ; 10 ( 1 ): 2162 .
Wang T , Liu Y , Zou JF , Cheng ZS . Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-beta1 mediated Smad2/3 and ERK1/2 activation . PLoS One . 2017 ; 12 ( 9 ): e0183972 .
Cipolla E , Fisher AJ , Gu H , Mickler EA , Agarwal M , Wilke CA , et al . IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis . FASEB J . 2017 ; 31 ( 12 ): 5543 - 56 .
Liu H , Mi S , Li Z , Hua F , Hu ZW . Interleukin 17A inhibits autophagy through activation of PIK3CA to interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial cells . Autophagy . 2013 ; 9 ( 5 ): 730 - 42 .
Chrysanthopoulou A , Mitroulis I , Apostolidou E , Arelaki S , Mikroulis D , Konstantinidis T , et al . Neutrophil extracellular traps promote differentiation and function of fibroblasts . J Pathol . 2014 ; 233 ( 3 ): 294 - 307 .
Heo YJ , Oh HJ , Jung YO , Cho ML , Lee SY , Yu JG , et al . The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1 . Arthritis Res Ther . 2011 ; 13 ( 4 ): R113 .
Wei L , Liu M , Xiong H , Peng B . Up-regulation of IL-23 expression in human dental pulp fibroblasts by IL-17 via activation of the NF-kappaB and MAPK pathways . Int Endod J . 2018 ; 51 ( 6 ): 622 - 31 .
Yang XO , Chang SH , Park H , Nurieva R , Shah B , Acero L , et al . Regulation of inflammatory responses by IL-17F . J Exp Med . 2008 ; 205 ( 5 ): 1063 - 75 .
Hot A , Miossec P . Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes . Ann Rheum Dis . 2011 ; 70 ( 5 ): 727 - 32 .
Glatt S , Baeten D , Baker T , Griffiths M , Ionescu L , Lawson ADG , et al . Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation . Ann Rheum Dis . 2018 ; 77 ( 4 ): 523 - 32 .
Chang SH , Dong C . IL-17F: regulation, signaling and function in inflammation . Cytokine . 2009 ; 46 ( 1 ): 7 - 11 .
Li H , Chen J , Huang A , Stinson J , Heldens S , Foster J , et al . Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family . Proc Natl Acad Sci U S A . 2000 ; 97 ( 2 ): 773 - 8 .
Shi Y , Ullrich SJ , Zhang J , Connolly K , Grzegorzewski KJ , Barber MC , et al . A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity . J Biol Chem . 2000 ; 275 ( 25 ): 19167 - 76 .
Ramirez-Carrozzi V , Ota N , Sambandam A , Wong K , Hackney J , Martinez-Martin N , et al . Cutting edge: IL-17B uses IL-17RA and IL-17RB to induce Type 2 inflammation from human lymphocytes . J Immunol . 2019 ; 202 ( 7 ): 1935 - 41 .
Kouri VP , Olkkonen J , Ainola M , Li TF , Bjorkman L , Konttinen YT , et al . Neutrophils produce interleukin-17B in rheumatoid synovial tissue . Rheumatology (Oxford) . 2014 ; 53 ( 1 ): 39 - 47 .
Reynolds JM , Lee YH , Shi Y , Wang X , Angkasekwinai P , Nallaparaju KC , et al . Interleukin-17B antagonizes interleukin-25-mediated mucosal inflammation . Immunity . 2015 ; 42 ( 4 ): 692 - 703 .
Yamaguchi Y , Fujio K , Shoda H , Okamoto A , Tsuno NH , Takahashi K , et al . IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis . J Immunol . 2007 ; 179 ( 10 ): 7128 - 36 .
Macgregor CH . Biosynthesis of membrane-bound nitrate reductase in Escherichia coli: evidence for a soluble precursor . J Bacteriol . 1976 ; 126 ( 1 ): 122 - 31 .
Yang D , Chen X , Wang J , Lou Q , Lou Y , Li L , et al . Dysregulated lung commensal bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles . Immunity . 2019 ; 50 ( 3 ): 692-706. e7 .
Shabgah AG , Fattahi E , Shahneh FZ . Interleukin-17 in human inflammatory diseases . Postepy Dermatol Alergol . 2014 ; 31 ( 4 ): 256 - 61 .
Larocque-De-Freitas IF , Rocha JDB , Nunes MP , Oliveira PV , Nascimento DO , Freire-De-Lima L , et al . Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection . Sci Rep . 2018 ; 8 ( 1 ): 16378 .
Wonnenberg B , Jungnickel C , Honecker A , Wolf L , Voss M , Bischoff M , et al . IL-17A attracts inflammatory cells in murine lung infection with P. aeruginosa . Innate Immun . 2016 ; 22 ( 8 ): 620 - 5 .
Wolf L , Sapich S , Honecker A , Jungnickel C , Seiler F , Bischoff M , et al . IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia . Am J Physiol Lung Cell Mol Physiol . 2016 ; 311 ( 5 ): L1015 - 22 .
Chang SH , Reynolds JM , Pappu BP , Chen G , Martinez GJ , Dong C . Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E . Immunity . 2011 ; 35 ( 4 ): 611 - 21 .
Hurst SD , Muchamuel T , Gorman DM , Gilbert JM , Clifford T , Kwan S , et al . New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25 . J Immunol . 2002 ; 169 ( 1 ): 443 - 53 .
Conti HR , Whibley N , Coleman BM , Garg AV , Jaycox JR , Gaffen SL . Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis . PLoS One . 2015 ; 10 ( 4 ): e0122807 .
Wynn TA . Integrating mechanisms of pulmonary fibrosis . J Exp Med . 2011 ; 208 ( 7 ): 1339 - 50 .
Weiskirchen R , Weiskirchen S , Tacke F . Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications . Mol Aspects Med . 2019 ; 65 : 2 - 15 .
Cai T , Qiu J , Ji Y , Li W , Ding Z , Suo C , et al . IL-17-producing ST2(+) group 2 innate lymphoid cells play a pathogenic role in lung inflammation . J Allergy Clin Immunol . 2019 ; 143 ( 1 ): 229-44. e9 .
Vella G , Ritzmann F , Wolf L , Kamyschnikov A , Stodden H , Herr C , et al . IL-17C contributes to NTHi-induced inflammation and lung damage in experimental COPD and is present in sputum during acute exacerbations . PLoS One . 2021 ; 16 ( 1 ): e0243484 .
Angkasekwinai P , Park H , Wang YH , Wang YH , Chang SH , Corry DB , et al . Interleukin 25 promotes the initiation of proallergic type 2 responses . J Exp Med . 2007 ; 204 ( 7 ): 1509 - 17 .
Xu M , Dong C . IL-25 in allergic inflammation . Immunol Rev . 2017 ; 278 ( 1 ): 185 - 91 .
Tamachi T , Maezawa Y , Ikeda K , Kagami S , Hatano M , Seto Y , et al . IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice . J Allergy Clin Immunol . 2006 ; 118 ( 3 ): 606 - 14 .
Saenz SA , Siracusa MC , Perrigoue JG , Spencer SP , Urban JF Jr , Tocker JE , et al . IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses . Nature . 2010 ; 464 ( 7293 ): 1362 - 6 .
Neill DR , Wong SH , Bellosi A , Flynn RJ , Daly M , Langford TK , et al . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity . Nature . 2010 ; 464 ( 7293 ): 1367 - 70 .
Xu X , Luo S , Li B , Dai H , Zhang J . Feature Article: IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts . Exp Biol Med (Maywood) . 2019 ; 244 ( 9 ): 770 - 80 .
Hams E , Armstrong ME , Barlow JL , Saunders SP , Schwartz C , Cooke G , et al . IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis . Proc Natl Acad Sci U S A . 2014 ; 111 ( 1 ): 367 - 72 .
Campa M , Mansouri B , Warren R , Menter A . A review of biologic therapies targeting IL-23 and IL-17 for use in moderate-to-severe plaque psoriasis . Dermatol Ther (Heidelb) . 2016 ; 6 ( 1 ): 1 - 12 .
Mease PJ , Genovese MC , Greenwald MW , Ritchlin CT , Beaulieu AD , Deodhar A , et al . Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis . N Engl J Med . 2014 ; 370 ( 24 ): 2295 - 306 .
Chiricozzi A , Krueger JG . IL-17 targeted therapies for psoriasis . Expert Opin Investig Drugs . 2013 ; 22 ( 8 ): 993 - 1005 .
Marzo-Ortega H , Sieper J , Kivitz A , Blanco R , Cohen M , Delicha EM , et al . Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2 . RMD Open . 2017 ; 3 ( 2 ): e000592 .
0
浏览量
0
Downloads
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621